![Carole Sable](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Carole A. Sable is currently an Independent Non-Executive Director at Basilea Pharmaceutica AG since 2023.
Former positions include Executive Director-Clinical Research at Merck & Co., Inc. from 1995 to 2007, Vice President at Merck & Co., Inc. from 2010 to 2013, Chief Medical Officer at Vitae Pharmaceuticals LLC in 2016, Assistant Professor at the University of Virginia from 1993 to 1995, Chief Medical Officer at SCYNEXIS, Inc. from 2014 to 2015, Chief Medical Officer at Novexel SA from 2009 to 2010, Head-Clinical Development at Antabio SAS from 2018 to 2021, and Chief Medical Officer at Revolution Medicines, Inc. from 2015 to 2016.
Education includes a doctorate from Thomas Jefferson University, a doctorate from Sidney Kimmel Medical College conferred in 1983, and an undergraduate degree from the University of Scranton.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Direttore/Membro del Consiglio | 27/04/2023 |
| Società | Posizione | Fine |
|---|---|---|
Antabio SAS
 Antabio SAS Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Direttore Tecnico/Scientifico/R&S | 01/01/2021 |
| VITAE PHARMACEUTICALS INC | Direttore Tecnico/Scientifico/R&S | 01/11/2016 |
| REVOLUTION MEDICINES, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2016 |
| SCYNEXIS, INC. | Direttore Tecnico/Scientifico/R&S | 20/02/2015 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2013 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Novexel SA
 Novexel SA Pharmaceuticals: MajorHealth Technology Researches and develops anti-infective drugs for the treatment of bacterial and fungal infections | Health Technology |
University of Scranton
 University of Scranton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Sidney Kimmel Medical College
 Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antabio SAS
Antabio SAS Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Health Technology |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
